Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 April 2019 | Story Rulanzen Martin | Photo Charl Devenish
Odeion Dean
From left; Dr Chitja Twala, Vice-Dean of the Faculty of Humanities; Prof Heidi Hudson and Marius Coetzee at the OSM Dean’s Gala Concert.

It was a night where the Odeion School of Music (OSM) had its finest and best talent on the stage. The OSM Dean’s Gala Concert 2019 delivered a spectacular show on Friday 5 April 2019.

“I am deeply honoured to have the dean’s office associated with this concert. The work done by OSM counts amongst the best in the Faculty. The staff and students of the Odeion and the Camerata are known for having received many awards and accolades over the last couple of years,” said Prof Heidi Hudson, Dean of the Faculty of The Humanities. The OSM also ensures that a vibrant concert culture is maintained. 

“I want to recognise the work done by educators not only at school level and tertiary level. Through music education the human soul is developed and preserved, which reminds us why arts and humanities are essential in pursuit of knowledge,” she said.

Heinrich Armer, former lecturer at the OSM was awarded the Order of The Odeion School of Music for his contribution to music.

“The concert is also a benefit concert for potential funders to see the talent the OSM has to offer,” said Marius Coetzee, Innovation Manager at the OSM. The main reasons for the concert is twofold; firstly to create a professional performance for the gifted OSM students and showcase their excellence. For some students it will be their debut performance. Secondly, it is to raise funds for bursaries and funding of future OSM students.”

The programme line-up showcased the best of the OSM with performances from the OSM Camerata conducted by Elsabe Raath, The Free State Wind Ensemble conducted by Danre Strydom, and Naledi Dweba (clarinet) with Anneke Lamont (Piano) among others. 

Steve Reich’s Clapping Music was also amusingly performed by Misumzi Bottoman, Heinrich Lategan and Marlou Strydom. Charity Leburu and Mirriam Bokala were the sopranos and were both accompanied by Margot Viljoen on the piano.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept